Lobbying

Provention Bio's latest lobbying report covers Q4 2023, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Health Issues.

Provention Bio

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Provention Bio lobbying by quarter
Provention Bio lobbying by quarter
QuarterAmountReports
Q4 2022$40K1
Q1 2023$20K1
Q2 2023$20K1
Q3 2023$01
Q4 2023$01
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$80K · 3 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES3 reports
  • SENATE3 reports
  • Natl Institutes of Health (NIH)1 reports

Firms it paid

Firm
Arnold & Porter Kaye Scholer$80K5 quarters

Former officials lobbying for it

Former position
CASEY BROUHARDHealth Counsel, Rep. Burgess (2019-2020); Intern, House Energy & Commerce Committee (2019)Q4 2022
GRACE BANFIELDIntern, Rep. Krishnamoorthi (2019)Q4 2022

Lobbying reports

Filed by
24/01/19for Q4 2023Arnold & Porter Kaye ScholerUnder $5,000
23/10/16for Q3 2023Arnold & Porter Kaye ScholerUnder $5,000
23/07/19for Q2 2023Arnold & Porter Kaye Scholer$20K
23/04/14for Q1 2023Arnold & Porter Kaye Scholer$20K
23/01/18for Q4 2022Arnold & Porter Kaye Scholer$40K